Why Clinical Trial Recruitment Fails — and What Actually Works
Participant recruitment is one of the most persistent — and most underestimated — risks to clinical study success. Industry analyses routinely find that a large share of studies miss their original enrolment timelines, and that delays at this stage cascade into every downstream milestone. Yet the cause is rarely the science or the regulation. It is that recruitment assumptions, however carefully built, break down the moment they meet reality at site level.
Sponsors and CROs have responded by investing more: better patient-engagement tools, specialist recruitment vendors, and ever more detailed feasibility work. These help. But they do not address the underlying problem — a recruitment plan that looks convincing on paper but was never stress-tested against how studies are actually run. This article looks at why that gap persists, where plans tend to fail, and what a more realistic approach looks like.
The gap between the plan and the reality
On paper, most recruitment strategies look strong. Feasibility responses are positive, timelines are confident, and site-by-site projections add up to a comfortable margin over target. Then the study goes live and enrolment stalls. Sites that promised ten patients deliver two. The pipeline that looked healthy turns out to depend on a handful of investigators who are already stretched across competing trials.
This gap between what looks good in planning and what is sustainable in practice is where most timelines are quietly lost. It is also why simply adding more sites or more budget seldomly fixes a struggling study: if the original assumptions were optimistic, scaling them up just multiplies the same error. The more useful question is not “how do we recruit faster?” but “which of our assumptions are most likely to be wrong, and how would we know, and fix them early?”
Where recruitment plans break down
Across studies that struggle, a familiar set of patterns shows up again and again:
- Feasibility data taken at face value. Sites are incentivised to be optimistic, and feasibility questionnaires capture intent far better than they capture capacity. Without critical interpretation, rosy estimates go unchallenged until enrolment proves them wrong.
- Protocol complexity. Restrictive eligibility criteria, heavy visit schedules, and demanding procedures all shrink the realistically eligible population. Design choices that look manageable in a protocol meeting can halve the available pool at site level.
- Misalignment between sponsors, CROs, and sites. Each party often holds a slightly different version of the recruitment plan and a different view of who owns the risk. That misalignment surfaces only once enrolment is already behind.
- Day-to-day site constraints. Staff time, competing studies, patient flow, and referral pathways rarely match the assumptions on the page. The site that looked ideal in selection may have no spare coordinator capacity when the study opens.
- Tools and vendors used as a default, not a decision. Recruitment technology and outreach vendors can add real value — but bolted onto a flawed plan, they add cost and complexity without guarantee solving the underlying mismatch.
None of these are exotic failures. They are ordinary, predictable, and recurring — which is precisely why they reward teams who learn to anticipate them. The good news is that most can be spotted and mitigated early if you build in regular reality checks and contingency planning from the start.
What actually works
Generic best practices are not the fix; most teams already know them. What separates studies that recruit well is judgement — the ability to read a recruitment plan critically and act on what the data is really telling you. In practice, that comes down to a few habits.
Interpret feasibility data critically. Treat site estimates as claims to be tested, not facts to be totalled. Probe the basis for projections, look for corroborating evidence such as historical enrolment in comparable studies, and discount accordingly.
See recruitment from the site’s perspective. Understand the competing demands, staffing realities, and patient pathways that determine whether a site can actually deliver. A plan built around real constraints is far more robust than one built around its best intentions.
Spot early warning signs. Slow start-up, screening ratios that drift from projections, or a pipeline concentrated in too few sites are all signals that the plan needs revisiting — well before the timeline is formally at risk.
Align expectations early and have mitigation ready. Get sponsors, CROs, and sites working from the same realistic plan, with shared ownership of the assumptions and a common view of what success looks like.
Mitigate quickly when a site struggles. Re-assess capacity on the ground, simplify procedures where possible, activate backup referral pathways or temporary support, intensify targeted outreach, and re-allocate targets to stronger sites while keeping the struggling site engaged.
Done consistently, these habits shift recruitment from a hopeful forecast to a managed risk — and that is usually the difference between a study that holds its timeline and one that does not.
Build the judgement to get recruitment right
ECCRT’s one-day workshop, Clinical Study Recruitment: Why Enrolment Fails and What Works, is built around exactly this challenge. Rather than promoting generic best practices, it moves beyond theory to examine how recruitment decisions are actually made, where assumptions tend to break down, and why misalignment between sponsors, CROs, and sites keeps undermining enrolment.
Through real-world examples drawn from practice — studies that struggled and studies that succeeded — you will strengthen the critical thinking behind feasibility assessment, recruitment planning, and execution at site level. You will learn to challenge unrealistic expectations, recognise early warning signs, and design recruitment approaches that are realistic, sustainable, and aligned with how studies are genuinely conducted.
Who it’s for: clinical project and study managers, clinical operations professionals (sponsor or CRO), feasibility and start-up teams, CRAs, and site-facing staff involved in recruitment planning, identification, or screening.
What’s included: course materials and a globally recognised certificate on completion. The workshop is led by ECCRT trainer Griet Rebry.
Next session: 29 October 2026, Brussels. Also available as a tailored in-house course delivered to your team.